Committee Connection

Editorial Board

Jonathan S. Berek, MD, MMS, FASCO, is the Laurie Kraus Lacob Professor and Director of the Stanford Women's Cancer Center at the Stanford Cancer Institute, where he specializes in gynecologic oncology. He is also Chair of the Department of Obstetrics and Gynecology at Stanford University School of Medicine. Dr. Berek served on the Scientific Program, Cancer Education, and Integrated Media and Technology Committees and Tumor Markers Expert Panel. He has been Editor-in-Chief of ASCO Connection (previously ASCO News & Forum) since 2004.
Al B. Benson III, MD, FASCO, is a Professor of Medicine in the Division of Hematology/Oncology at Northwestern University's Feinberg School of Medicine, Associate Director for Clinical Investigations and Chair of the Clinical Protocol Scientific Review and Monitoring System for the Robert H. Lurie Comprehensive Cancer Center, and an Attending Physician at Northwestern Memorial Hospital. He specializes in gastrointestinal malignancies, including colorectal cancer. He currently serves on the ASCO Gastrointestinal Guideline Advisory Group.

Susan Lerner Cohn, MD, is Director of Clinical Sciences, Section of Pediatric Oncology/Hematology, at Comer Children's Hospital at the University of Chicago, Dean for Clinical Research for the Biological Sciences Division, and a Professor of Pediatrics at The University of Chicago. Dr. Cohn's research interests include pediatric cancers, particularly neuroblastoma. She is one of a few pediatric oncologists conducting phase I clinical trials of treatments for neuroblastoma. In addition to her role on the ASCO Connection Editorial Board, Dr. Cohn serves as Treasurer on the ASCO Board of Directors and sits on the Finance, Bylaws, and Audit Committees.

Sabha Ganai, MD, PhD, is a Surgical Oncologist and Director of Gastrointestinal Oncology at the Simmons Cancer Institute at Southern Illinois University.  Her research interests include rural health geographics, translational research related to the mechanisms of metastasis, as well as ethics education. She served on the ASCO University Fellows Council and currently serves on the ASCO Integrated Media and Technology Committee. Follow Dr. Ganai on Twitter @DrSabha.
Stuart A. (Skip) Grossman, MD, is a Professor of Oncology, Medicine, and Neurosurgery at the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center. His clinical interests include developing novel therapeutic strategies for patients with primary and metastatic brain tumors, leptomeningeal metastases, and cancer pain.
Stephen Leong, MD, is an Associate Professor of the Division of Medical Oncology in the School of Medicine at the University of Colorado. His areas of interest are gastrointestinal malignancies and developmental therapeutics, where he focuses on investigating novel agents in colorectal cancers.

Robert G. Mennel, MD, FASCO, specializes in medical oncology and hematology at Texas Oncology-Baylor Charles A. Sammons Cancer Center in Dallas, Texas. Dr. Mennel is board certified in both internal medicine and medical oncology; his primary research interests are head and neck cancers. He has served on the Breast Cancer Tumor Markers, Gastrointestinal Tumor Markers, Cancer Education, and Oncology Training Programs Committees

Hope S. Rugo, MD, is a medical oncologist specializing in breast cancer research and treatment at the University of California, San Francisco. She is also a Professor of Medicine, Director of the Breast Oncology and Clinical Trials Education, and is the principal investigator of multiple clinical trials focusing on combining novel targeted therapeutics with standard treatment to improve the treatment of both early and late stage breast cancer. Dr. Rugo has been a member of ASCO since 1994, serving on the Scientific Program Committee, Education Committee, and Membership Committee. She is the editor of the Breast Cancer Section for


Alan Sandler, MD,is Principal Medical Director for Genentech. He is the author or co-author of more than 200 published articles, book chapters, reviews, and abstracts involving the clinical activity of chemotherapy and novel targeted agents, with a particular emphasis on lung cancer. An ASCO member since 1993, he has served on the Cancer Education and Scientific Program Committees.


Jennifer S. Temel, MD, an ASCO member since 2002, is the Clinical Director of Thoracic Oncology and Director of Cancer Outcomes Research at the Massachusetts General Hospital (MGH)Cancer Center. Prior to this appointment, she completed her fellowship at the Dana Farber Cancer Institute/MGH combined program, performed her residency at Brigham and Women's Hospital, and graduated from the Washington University School of Medicine in St. Louis. Her research area of interest is palliative and end of life care in patients with advanced cancer. An ASCO member since 2002, Dr. Temel currently sits on the Palliative Care in Oncology Symposium Planning Committee and the Journal of Clinical Oncology Editorial Board.